# BnJ Biopharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bnj-biopharma

- Industry: Biotechnology
- Headquarters: Incheon, South Korea
- Website: www.bnjbio.com/
- Latest round: Seed (Jul 24, 2023)
- Investors on record: 4

## About

Based in Incheon, South Korea, and founded in 2021, BnJ Biopharma Inc. operates as a biotechnology firm developing anticancer medications based on intratumoral diversity data. In December 2023, BnJ Biopharma Inc. raised an undisclosed amount of venture funding from new investor The Invention Lab. As of December 2023, Dong Jae-joon is the Chief Executive Officer (CEO) of the company. BnJ Biopharma specializes in anticancer drug development using intratumor diversity data. The company creates an advanced approach to increasing early-stage anticancer drug development through intratumoral differences insights, which could reduce the typical decade-long process to five years. This ground-breaking strategy aims at fighting resistance in existing anticancer drugs, promising significant advances in the field.

## Funding rounds

- Seed, Jul 24, 2023 — BigBang Angels, Korea Tech Incubator for Startup
- Seed, May 31, 2022 — Idea Bridge Asset Management, Innocuve

## Investors

- Idea Bridge Asset Management — Seed
- Innocuve — Seed
- BigBang Angels (https://capitalatlas.ai/funds/bigbang-angels) — Seed
- Korea Tech Incubator for Startup — Seed